Requiring insurers, nonprofit health service plans, and health maintenance organizations to provide coverage for a certain supply of prescription drugs used for gender-affirming care, hormone therapy, or reproductive health in certain circumstances; and altering the amount of certain prescription drugs that a pharmacist is allowed to dispense on or after January 1, 2027.